ENCell
Latest round
- Series B
Last raised
- Jun 2021
Total raised
- $32M
Investors
- 9
About ENCell
Founded in 2018 and based in Seoul, South Korea, ENCell is a stem cell company that specializes in the development of rare disease drugs using stem cells. Jang Jong-wook is the founder and CEO of the company. The company offers services including consignment production of advanced biopharmaceuticals (CMO), advanced biopharmaceutical consignment development (CDO), and microbial verification service. media and water for injection verification services, residue verification services, cell characteristics analysis verification services, and manufacturing environment verification services. The firm provides GMP facilities and operates for cell and gene therapy and provides customized services for the entire drug development cycle, from initial development to product approval at the request of customers. ENCell also improves the quality of life of patients and provides fundamental treatment of rare and incurable diseases through the development of stem cell processes and the development of next-generation stem cell drugs for rare and incurable diseases. In 2021, the startup generated revenue of KRW 3900 million. The company plans to use the December 2025 funds to commercialize its treatment EN001, support research and development, and expand its new anti-aging product line.
Who invested in ENCell
9 investors across 2 rounds
See all investors in ENCell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ENCell
Who invested in ENCell?
ENCell has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ENCell raised?
ENCell has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ENCell last raise money?
ENCell's most recent round on record is a Series B, in Jun 2021.
What does ENCell do?
Founded in 2018 and based in Seoul, South Korea, ENCell is a stem cell company that specializes in the development of rare disease drugs using stem cells.
Where is ENCell headquartered?
ENCell is headquartered in Seoul, South Korea.
Which VCs invest in companies like ENCell?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ENCell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ENCell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.